Clinical Trials Directory

Trials / Completed

CompletedNCT05875779

Peer Education as a Strategy to Promote Vaccine Acceptance

Developing Vaccine Educators Within Practices of Community Healthcare Providers: a Pragmatic, Randomized Controlled Trial of Peer Education to Promote Vaccine Acceptance

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
154 (actual)
Sponsor
NYU Langone Health · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Effective interventions to improve uptake of vaccines among hesitant groups are urgently needed. Peer education is an effective intervention in modifying health behaviors in other conditions and may be effective in promoting vaccine confidence but has not been studied. To fill this knowledge gap, we will enroll approximately 152 parents of children age 0-18 months who are eligible for pneumococcal conjugate (PCV-13) vaccine and randomize them 1:1 to a peer-led vaccine education intervention or usual care.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPeer-led vaccine education interventionThe intervention will be delivered face-to-face by a trained peer-educator and will consist of one session of 10-20 minutes. Peer vaccine educators will receive written vaccine materials for distribution. These materials will present content that accurately represents the risks and benefits of vaccination. Responsibilities of the vaccine educators will be to: provide motivational interviewing with patients, provide vaccine counseling, address questions and concerns regarding available vaccines, brief clinical provider on hesitant patients and areas of their vaccine-related concerns, and provide follow-up with participants at day 30, day 60 and day 90 for additional engagement.

Timeline

Start date
2022-03-06
Primary completion
2023-05-27
Completion
2023-08-01
First posted
2023-05-25
Last updated
2023-08-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05875779. Inclusion in this directory is not an endorsement.